-
平臺(tái)編號(hào)：bio-105321
-
國際編號(hào)：ATCC 51435
-
拉丁屬名： Escherichia coli
-
規(guī)格：freeze-dried
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
大腸埃希氏菌
Escherichia coli (Migula) Castellani and Chalmers 拉丁名
ATCC 51435 編號(hào)
Classification Enterobacteriaceae, Escherichia
Strain Designations 菌種別名 B2F1
Application 用途 Produces Shiga-like toxin II
Enteric Research
Isolation 分離基物 Clinical specimen - human
Canada
Biosafety Level 安全等級(jí) 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Antigenic Properties Serotype O91:H21
Product Format 提供形式 freeze-dried
Preceptrol no
Type Strain 模式菌株 no
Antigenic Properties Serotype O91:H21
Medium 培養(yǎng)基 ATCC Medium 1065: LB Agar/Broth, Miller
Growth Conditions 生長條件
Temperature 培養(yǎng)溫度 : 37.0°C
Name of Depositor 寄存者 AD O'Brien
Chain of Custody 來源國家 ATCC <<--AD O'Brien<<--M.A. Karmali
Isolation 分離基物 Clinical specimen - human
Canada
References 參考文獻(xiàn)
Lindgren SW, et al. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect. Immun. 62: 623-631, 1994. PubMed: 8300218
Lindgren SW, et al. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect. Immun. 61: 3832-3842, 1993. PubMed: 8359904
Ito H, et al. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome. Microb. Pathog. 8: 47-60, 1990. PubMed: 2185397
Oku Y, et al. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2). Microb. Pathog. 6: 113-122, 1989. PubMed: 2654533
patient with hemolytic uremic syndrome, Toronto
ATCC51435
